<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Asthma</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="874" role="article" about="/commodorecompendium/asthma" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Asthma – Trent Goodin, Stacy Blank</span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Ask about triggers: cold, exercise, URIs, allergens, inhaled irritants</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Ask about family history or personal history of atopy, eczema, allergic rhinitis</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Exam: wheezing, prolonged expiratory phase; nasal polyps, rhinitis, eczema</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Evidence of reversible airflow obstruction (i.e. improvement of obstruction post-bronchodilator) or airway hyper-reactivity (methacholine challenge)</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Spirometry (PFT’s) with reversible obstruction </span></span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">FEV1/FVC &lt;0.7; </span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Wingdings 3&quot;"><span style="color:black">#</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> FEV1 12% and 200 mL after bronchodilator</span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">“All That Wheezes Is Not Asthma” rule out alternative diagnoses:</span></span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Panic attacks, upper airway obstruction, foreign body, vocal cord dysfunction, CHF (cardiac asthma), COPD, ILD</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Classify Severity and Assess for Symptom Control with the RULE OF 2s:  </span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Does the patient have symptoms or require rescue inhaler </span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Cambria Math&quot;,serif"><span style="color:black">≥</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">2 times per week?</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Does the patient endorse nighttime symptoms </span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Cambria Math&quot;,serif"><span style="color:black">≥ </span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">2 times per month?</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Does the patient have to refill rescue inhaler </span></span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Cambria Math&quot;,serif"><span style="color:black">≥ </span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">2 times per year?</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Does the patient ever have to limit activity due to asthma symptoms?</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Initial Assessment of Severity:</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Intermittent: No to all of the above and FEV1&gt; 80% predicted. Start at step 1</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Persistent: Yes to any question above. Start at Step 2</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Mild</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">:  Less than daily symptoms, less than weekly nighttime symptoms, minor limitation to activities</span></span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">FEV</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> &gt;80% predicted</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Moderate:  Daily symptoms, weekly nighttime symptoms, some limitation to activities</span></span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">FEV</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> 60-80% predicted</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Severe: More severe symptoms than above, FEV1 &lt;60% predicted</span></span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Consider</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> referral to pulmonary</span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Aim to use the lowest possible step to maintain symptom control. Also consider stepping down therapy if pt has been well-controlled for &gt;3 months</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Prior to escalating therapy, consider: </span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Adherence to therapy (including inhaler technique), uncontrolled comorbidities (allergies, GERD, OSA, etc), and alternative diagnoses</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Ensure patients receive MDI and spacer teaching for full effect. </span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Updated Guidelines: prn ICS - LABA &gt; prn SABA Step 1 (mild intermittent) and Step 2 (mild persistent)</span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Reduces exacerbations, easier to schedule does in future if needed</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">SYGMA Trial showed rescue/prn Budesonide-formoterol (ICS - LABA) non-inferior to daily ICS-LABA + prn SABA in preventing exacerbations</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Additional Information </span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Follow-up</span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Repeat</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> PFTs q3-6 mosafter beginning therapy and q1-2 yrs thereafter</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Regular follow up at least q6 mos for all patients with asthma</span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">VA specific guidance:  </span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="vertical-align:baseline"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Mometasone</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> is the formulary ICS and Symbicort (budesonide-formoterol) is the formulary ICS/LABA</span></span></span></span></span></span></li>
<li><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"><span style="color:black">Ordering</span></span></span></span><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"> PFTs: Refer to Pulm section on PFTs for VUMC and VA specifics</span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<p><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"><img alt="Asthma" data-entity-type="file" data-entity-uuid="f657a07a-26a7-49a4-8f74-4b4bac5b73a7" src="/sites/default/files/inline-images/Asthma.png"/></span></span></span></p>
</div>
</div>
</article>
</div>
</div>